Colin Goudelocke, Keith Xavier, Barry Pecha, Kimberly Burgess, Marie-A Perrouin-Verbe, Ryan Krlin, Jodi Michaels, Sagar Shah, Benoît Peyronnet, Stanley Zaslau, Mylène Champs, Bianca Papi, Katie Bittner, Dean Elterman, Victor Nitti
AIMS: Sacral neuromodulation (SNM) is an advanced therapy option for the treatment of overactive bladder (OAB), nonobstructive urinary retention, and fecal incontinence. The aim of this ongoing prospective, multicenter, global, postmarket study is to confirm safety and clinical performance of the InterStimTM Micro system for SNM in all indications. Reported here are the results for the OAB cohort through 6-month follow-up. METHODS: Eligible OAB subjects that had a successful therapy evaluation were enrolled after implant of an InterStim Micro implantable pulse generator (IPG)...
March 14, 2023: Neurourology and Urodynamics